NLRC4 and colonic neoplasm: Mice lacking NLRP3 or NLRC4 show higher susceptibility to colon cancer following AOM-DSS treatment, and aberrant inflammasome formation leads to inhibition of tumor suppressor genes such as p53 and over-activation of oncogenes such as Wnt.